通过原生细胞突变和发酵优化,增强了微单子 inyoensis 中的西索米辛的产生
Jianguo Xu1,2, Shulin Shen3,4, Zhehua Hu1
1Laboratory of Pharmaceutical Engineering, School of Life Science and Health Engineering, Jiangnan University, Wuxi, 214122, China.
Applied biochemistry and biotechnology
|February 21, 2024
概括
这项研究通过化学突变发生和优化发酵条件开发了一种高产品种,从而增强了西索米辛 (一种广泛的氨基糖类抗生素) 的产生. 由此产生的菌株达到创纪录的发酵位1780U·mL-1 .
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 发酵科学 发酵科学
背景情况:
- 西索米辛是一种关键的氨基甘油酸抗生素,也是网尔米辛和等离子素的前体,其发酵产量较低.
- 有限的生产限制了西索米辛及其临床重要衍生物的更广泛应用.
研究的目的:
- 通过菌株繁殖和发酵优化,显著改善西索米辛的生产.
- 为了实现西索米的最高可能的发酵位.
主要方法:
- 在原生体上使用二甲基硫酸盐的Micromonospora inyoensis OG-1的化学变异.
- 查高产量,基因稳定的突变菌株.
- 优化碳和来源以及发酵中的溶氧水平.
主要成果:
- 开发出了一种高产的突变菌株 (H6-32),该菌株增加了42.6%的西索米辛标位,达到1486 U·mL-1 .
- 优化的发酵条件,包括溶解氧控制,最终产生了1780U·mL-1的西索米辛标位.
- 对基因组进行比较分析,在高产品菌株H6-32.2中发现了13种基因突变.
结论:
- 该研究成功开发了一种高产的西索米辛菌株,并优化了发酵,实现了创纪录的标位.
- 这项工作为未来的菌株开发和在抗生素生产中优化发酵过程提供了宝贵的参考.
- 这一发现有助于更深入地了解西索米辛过度生产的遗传基础.
相关概念视频
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Alcohol
Continuous fermentation is a key strategy in industrial ethanol production, particularly when efficiency, scalability, and high yields are essential. This approach allows for uninterrupted operation and optimized resource utilization. The primary feedstock, corn starch, undergoes enzymatic hydrolysis facilitated by α-amylase and glucoamylase. These enzymes break down the starch into fermentable sugars such as glucose, which are readily assimilated by fermentative microorganisms.Fermentation...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
iChip
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...


